Skip to content

Clinical trials

Leukemia, B-Cell trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, B-Cell Country / region: Canada Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20063
20081
20092
20101
20141
20171
20191
20211
20221
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting5
Completed4
Terminated4
Active, not recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
AstraZeneca2
University Health Network, Toronto2
AbbVie (prior sponsor, Abbott)1
Acerta Pharma BV1
British Columbia Cancer Agency1
Celgene1
Loxo Oncology, Inc.1
MedImmune LLC1
Merck Sharp & Dohme LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, B-Cell15
Leukemia, Lymphocytic, Chronic, B-Cell7
Lymphoma, Non-Hodgkin5
Recurrence4
Lymphoma, B-Cell3
Lymphoma, Mantle-Cell3
Neoplasms3
Hematologic Neoplasms2
Leukemia2
Lymphoma, Follicular2

Trials

Showing 26 to 15 of 15. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.